Macfarlane J D, Maisey M N, Grahame R, Burry H C
Rheumatol Rehabil. 1976 May;15(2):108-11. doi: 10.1093/rheumatology/15.2.108.
Feprazone, a new anti-inflammatory drug, is a useful antirheumatic preparation which causes little gastrointestinal upset. This short cross-over study shows no significant gastrointestinal blood loss with either feprazone or phenylbutazone by the red-cell chromium-51 labelling method.
非普拉宗,一种新型抗炎药,是一种有效的抗风湿制剂,几乎不会引起胃肠道不适。这项短期交叉研究表明,通过红细胞铬-51标记法,非普拉宗或保泰松均未出现明显的胃肠道失血情况。